Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

LIFELET

Financiado

Business plan optimisation and preparation for scaling of a transcatheter heart...

Business plan optimisation and preparation for scaling of a transcatheter heart valve replacement manufactured using automation Lifelet Medical is on a mission to deliver one valve for life for patients suffering from heart valve disease. Lifelet is developing a disruptive polymeric heart valve replacement to transcend the limitations of mechanical and ani... ver más

31/03/2024

LIFELET MEDICAL LI...

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

LIFELET MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU

Innovación

Cerrada hace 2 años

0% 100% 100%

1 Participantes

LIFELET MEDICAL LIMITED

75.00K€ | Lider

Proyectos interesantes

StreamlineValve Flow Controlled Prosthetic Heart Valves 150K€ Cerrado

GrownValve A prosthetic heart valve for adults and children, made from... 4M€ Cerrado

BIOMITRAL Engineering the mitral valve bioinspired control of structu... 2M€ Cerrado

The Angelvalve Project AVVie Advancing Transcatheter Mitral Valve Repair 9M€ Cerrado

PID2021-124868OB-C22 STENTS POLIMERICOS ADAPTABLES PARA TRATAR COARTACION AORTICA... 94K€ Cerrado

I3 Innovative Imaging Insights (I3): Development of MR-compatib... 174K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 10 meses Fecha Inicio: 2023-05-26
Fecha Fin: 2024-03-31

Líder del proyecto

LIFELET MEDICAL LIMITED

Presupuesto del proyecto 75K€

Descripción del proyecto Lifelet Medical is on a mission to deliver one valve for life for patients suffering from heart valve disease. Lifelet is developing a disruptive polymeric heart valve replacement to transcend the limitations of mechanical and animal tissue-based devices available to patients today. Combining the durability of mechanical valves with the blood compatibility and minimally invasive delivery of animal tissue valves, Lifelet’s fully synthetic device aims to enable improved patient outcomes and reduced complications with easier deliverability, enhanced durability, and cost savings for healthcare systems through automated manufacturing and processing. There are 1.2 million patients in the U.S. with severe aortic valve stenosis, and over half of these patients are symptomatic, requiring a heart valve replacement. The transcatheter aortic valve replacement (TAVR) market size is €4B, expected to growth to €7B+ by 2024, with a double-digit CAGR. Thanks to recent clinical trials, indications are being expanded for younger patients, asymptomatic patients, and those at low and intermediate risk for surgery, driving growth of the market. Cardiologists will Lifelet's device with existing reimbursement in place. As a platform technology, the Lifelet polymer may also offer clinical benefits in the treatment of obesity, gastrointestinal diseases, and incontinence. Elle Sander, female CEO and co-founder, is a biomedical engineer who has led the company to a proof-of-principle in chronic sheep studies and is a lead inventor of the material technology, with one patent granted in the EU already. Co-founder and CMO Dr. Faisal Sharif, consultant interventional cardiologist, has a track-record of implanting new devices and a extensive experience of clinical trial development and operations. The team have a passion to commercialise this deep tech, and have the vision to execute on what is required from technical, clinical, regulatory, and commercial perspectives.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores